Loading...
OTCM
RMHI
Market cap1mUSD
Dec 05, Last price  
2.85USD
1D
16.80%
1Q
171.43%
Jan 2017
7,025.00%
IPO
285.14%
Name

Peak Pharmaceuticals Inc

Chart & Performance

D1W1MN
OTCM:RMHI chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Peak Pharmaceuticals, Inc. operates as a bio­pharmaceutical and nutraceutical company in the United States. The company focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. It is involved in the development of over-the-counter, THC­free, hemp based products for human market for the prevention and alleviation of symptoms associated with inflammatory and auto-immune diseases. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.
IPO date
May 17, 2010
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

No data to show